SEC Form 4 · accession 0001437749-15-018265
CESCA THERAPEUTICS INC. · KOOL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mahendra S. Rao
Director
Period of report
Sep 30, 2015
Accepted (ET)
Oct 9, 2015 · 6:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000811212
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 30, 2015 | A | 7,075 | $0.53 | A | 21,209 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1As Chairman of the Clinical Program Review Committee, the reporting person receives common stock in lieu of cash for 50% of the committee fees.